1-phenyl-2-decanoylamino-3-morpholino-1-propanol and cycloserine

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with cycloserine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inokuchi, J; Radin, NS; Shukla, A; Shukla, GS1
Meredith, FI; Rentz, SS; Riley, RT; Showker, JL1

Other Studies

2 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and cycloserine

ArticleYear
Rapid kidney changes resulting from glycosphingolipid depletion by treatment with a glucosyltransferase inhibitor.
    Biochimica et biophysica acta, 1991, Apr-24, Volume: 1083, Issue:1

    Topics: Animals; Brain; Ceramides; Cycloserine; Galactosidases; Glucosidases; Glucosylceramides; Glucosyltransferases; Glucuronidase; Glycosphingolipids; Kidney; Kinetics; Liver; Mice; Mice, Inbred ICR; Morpholines; Organ Specificity; Reference Values; Sphingomyelin Phosphodiesterase

1991
Inhibition of sphingolipid biosynthesis decreases phosphorylated ERK2 in LLC-PK1 cells.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2005, Volume: 43, Issue:1

    Topics: Acyltransferases; Animals; Apoptosis; Cell Division; Cycloserine; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fumonisins; Glucosyltransferases; LLC-PK1 Cells; Mitogen-Activated Protein Kinase 1; Morpholines; Oxidoreductases; Phosphorylation; Serine C-Palmitoyltransferase; Sphingolipids; Swine

2005